| Financial Year |
March 31 2023 |
| Monetary Funds |
1,788,415,948.09 |
| Held-for-trading Financial Assets |
287,080,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
603,387,032.58 |
| Advances to Suppliers |
28,051,705.19 |
| Other Receivables |
24,599,639.06 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
468,610,797.67 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
29,253,038.19 |
| Total Current Assets |
3,234,048,160.78 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
42,700,928.97 |
| Investment Properties |
392,114,378.98 |
| Fixed Assetes |
437,852,871.31 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
45,633,820.13 |
| R&D expenses |
-- |
| Goodwill |
1,726,498.60 |
| Long-Term Deferred and Prepaid Expenses |
45,288,702.37 |
| Deferred Income Tax Assets |
75,491,487.05 |
| Other Non-Current Assets |
7,806,256.00 |
| Sub-Total of Non-Current Assets |
1,439,415,478.14 |
| Total Assets |
4,673,463,638.92 |
| Short-Term Loans |
438,281,124.76 |
| Trading Financial liabilities |
-- |
| Notes Payable |
125,465,898.55 |
| Accounts Payable |
406,010,355.34 |
| Accounts Received In Advance |
7,405,873.02 |
| Employee Compensation Payable |
55,366,675.45 |
| Taxes Payable |
41,237,262.73 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
62,067,253.03 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
77,077,251.33 |
| Other Current Liabilities |
14,920,374.72 |
| Sub-Total of Current Liabilities |
1,271,724,569.60 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
6,577,808.38 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
57,287,902.45 |
| Total Liabilities |
1,329,012,472.05 |
| Paid-In Capital(Or Share Stock) |
576,200,800.00 |
| Capital Surplus |
730,349,491.70 |
| Surplus Reserve |
121,185,151.37 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,770,543,563.16 |
| Minority Stockholder's Interest |
146,172,160.64 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,198,279,006.23 |
| Owner's Equity（Stockholder's Equity） |
3,344,451,166.87 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,673,463,638.92 |
